The company is actually called Ascendis Health, but one look at a share price chart and you’ll understand why I laughed when an ex-banking colleague called it Descendis Health in a chat we had a few weeks ago. With a nod to his genius, I’ve borrowed the name. If there was ever a poster child for a high-risk acquisitive strategy …
View PostThe company is actually called Ascendis Health, but one look at a share price chart and you’ll understand why I laughed when an ex-banking colleague called it Descendis Health in a chat we had a few weeks ago. With a nod to his genius, I’ve borrowed the name. If there was ever a poster child for a high-risk acquisitive strategy …
View PostThe company is actually called Ascendis Health, but one look at a share price chart and you’ll understand why I laughed when an ex-banking colleague called it Descendis Health in a chat we had a few weeks ago. With a nod to his genius, I’ve borrowed the name. If there was ever a poster child for a high-risk acquisitive strategy …
View PostInvestment analysis is hardly ever as simple as it initially seems. People are too quick to assume that an entire sector is going to do very well from a specific event. Let’s take healthcare as a topical example. With hospitals overflowing and medical infrastructure buckling under pressure in many countries worldwide, one may be quick to assume that companies in …
View Post